Women's Health Diagnostics Market Report 2023-2028: Top Companies Growth Outlook: Abbott Laboratories, Becton Dickinson and Company, bioMérieux SA
IMARC Group, a leading market research company, has recently releases a report titled “Women's Health Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global women's health diagnostics market size, report , share, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
The global women's health diagnostics market size reached US$ 23.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 37.3 Billion by 2028, exhibiting a growth rate (CAGR) of 7.51% during 2023-2028.
What is Security Women's Health Diagnostics?
Women's
health diagnostics refers to the comprehensive and evolving field of medical
assessments and tests specifically tailored to monitor, diagnose, and maintain
the well-being of women. It encompasses a broad spectrum of healthcare
procedures and examinations that address the health concerns and needs of
women. It also involves wellness screenings and preventative measures like
regular check-ups, cholesterol checks, and blood pressure monitoring. It
facilitates the early detection and prevention of various diseases, which
include breast cancer, cervical cancer, ovarian cancer, and uterine fibroids.
It aids in the management of chronic conditions that disproportionately affect
women, such as polycystic ovary syndrome (PCOS) and endometriosis.
Women's Health Diagnostics Market Demand, Industry Trends:
The
increasing prevalence of several chronic diseases among the female population
represents one of the key factors positively influencing the market.
Additionally, the rising number of women entering menopause and facing
age-related health challenges, such as osteoporosis and cardiovascular disease,
driving the demand for diagnostic services is driving the demand for diagnostic
services. Along with this, the growing emphasis on preventive healthcare is
encouraging women to seek regular check-ups and screenings.
Apart from
this, ongoing advancements in diagnostic technologies and the development of
digital mammography, three-dimensional (3D) ultrasounds, and non-invasive
prenatal testing are becoming more accessible and accurate, leading to earlier
and more precise diagnoses. These technological innovations are enhancing
patient outcomes and improving the overall healthcare experience for women.
Moreover, women are actively seeking information about their health and
advocating for comprehensive diagnostic evaluations, which is strengthening the
growth of the market.
Furthermore,
various healthcare companies and research institutions are investing heavily in
the development of innovative diagnostic tests and technologies specifically
tailored to the health needs of women. These ongoing research and development
(R&D) activities are expanding the range of available diagnostic options
and improving their accuracy. Along with this, the governing authorities of
various countries are undertaking initiatives and introducing policies that
focus on women's health, such as breast cancer screening programs and
subsidized preventive services.
Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/womens-health-diagnostics-market
Who are the leaders in the women's health diagnostics market?
- Abbott Laboratories
- Becton Dickinson and Company
- bioMérieux SA
- Cardinal Health Inc.
- Cook Group Incorporated
- F. Hoffmann-La Roche AG
- General Electric Company
- Hologic Inc.
- Koninklijke Philips N.V.
- Perkinelmer Inc.
- Quest Diagnostics Inc.
- Siemens AG
- Thermo Fisher Scientific Inc.
Breakup by
Type:
- Diagnostic
Devices
o
Biopsy Device
o
Imaging and Monitoring Devices
o
Accessories and Consumables
- Diagnostic
Tests
o
Breast Cancer Testing
o
PAP Smear and HPV Test
o
Pregnancy Testing and Ovulation Testing
o
Others
Breakup by
Application:
- Breast
Cancer
- Infectious
Disease Testing
- Osteoporosis
Testing
- Pregnancy
and Fertility Testing
- Sexually
Transmitted Disease Testing
- Others
Breakup by
End User:
- Hospital
and Diagnostics Centers
- Home Care
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
- Market Performance
- Market Outlook
- Porter's Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic, and technological developments for business leaders in pharmaceutical, industrial, and high-technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology, and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/
